Dilated cardiomyopathy classification: Difference between revisions

	Dilated cardiomyopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Classification
Causes
Differentiating Dilated cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dilated cardiomyopathy classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dilated cardiomyopathy classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dilated cardiomyopathy classification
CDC on Dilated cardiomyopathy classification
Dilated cardiomyopathy classification in the news
Blogs on Dilated cardiomyopathy classification
Directions to Hospitals Treating Dilated cardiomyopathy
Risk calculators and risk factors for Dilated cardiomyopathy classification

VisualWikitext

Latest revision as of 12:27, 30 December 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD [2]

Overview

Dilated cardiomyopathy can be classified in terms of etiology, according to the presence of ischemia (ischemic and non-ischemic) or the mode of inheritance (Familial and non-familial).

Classification

Dilated cardiomyopathy can be classified in terms of etiology ^[1]^[2]:

Based on the presence of ischemia
- Ischemic DCM: In which the underlying cause is related to ischemia like coronary artery disease.
- Non-ischemic DCM: In which ischemia was not he main driver of DCM pathogenesis.
Based on the mode of inheritance:
- Familial: In which an inherited genetic mutation started the myopathy process
- Non-familial: related to other causes as infections, toxins, drugs, and peripartum cardiomyopathy

References

↑ Sinagra G, Elliott PM, Merlo M (2019). "Dilated cardiomyopathy: so many cardiomyopathies!". Eur Heart J. doi:10.1093/eurheartj/ehz908. PMID 31872205.
↑ Rosenbaum AN, Agre KE, Pereira NL (2019). "Genetics of dilated cardiomyopathy: practical implications for heart failure management". Nat Rev Cardiol. doi:10.1038/s41569-019-0284-0. PMID 31605094.

Template:WH Template:WS

[pmid31872205-1] Sinagra G, Elliott PM, Merlo M (2019). "Dilated cardiomyopathy: so many cardiomyopathies!". Eur Heart J. doi:10.1093/eurheartj/ehz908. PMID 31872205.

[pmid31605094-2] Rosenbaum AN, Agre KE, Pereira NL (2019). "Genetics of dilated cardiomyopathy: practical implications for heart failure management". Nat Rev Cardiol. doi:10.1038/s41569-019-0284-0. PMID 31605094.

[1]

[2]

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Xyz}}
+{{Dilated cardiomyopathy}}
-{{CMG}}; {{AE}}
+{{CMG}}; {{AE}} {{AIA}}
 ==Overview==
-There is no established system for the classification of [disease name].
+[[Dilated cardiomyopathy]] can be classified in terms of [[etiology]], according to the presence of [[ischemia]] (ischemic and non-ischemic) or the mode of [[Heredity|inheritance]] ([[Familial]] and non-familial).
-OR
-[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
-OR
-[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
-[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
-OR
-Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
-OR
-If the staging system involves specific and characteristic findings and features:
-According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
-OR
-The staging of [malignancy name] is based on the [staging system].
-OR
-There is no established system for the staging of [malignancy name].
 ==Classification==
-There is no established system for the classification of [disease name].
+[[Dilated cardiomyopathy]] can be classified in terms of etiology <ref name="pmid31872205">{{cite journal| author=Sinagra G, Elliott PM, Merlo M| title=Dilated cardiomyopathy: so many cardiomyopathies! | journal=Eur Heart J | year= 2019 | volume=  | issue=  | pages=  | pmid=31872205 | doi=10.1093/eurheartj/ehz908 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31872205  }}</ref><ref name="pmid31605094">{{cite journal| author=Rosenbaum AN, Agre KE, Pereira NL| title=Genetics of dilated cardiomyopathy: practical implications for heart failure management. | journal=Nat Rev Cardiol | year= 2019 | volume=  | issue=  | pages=  | pmid=31605094 | doi=10.1038/s41569-019-0284-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31605094  }}</ref>:
-OR
-[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
-*[Group1]
-*[Group2]
-*[Group3]
-*[Group4]
-OR
-[Disease name] may be classified into [large number > 6] subtypes based on:
-*[Classification method 1]
-*[Classification method 2]
-*[Classification method 3]
-[Disease name] may be classified into several subtypes based on:
-*[Classification method 1]
-*[Classification method 2]
-*[Classification method 3]
-OR
-Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
-OR
-'''If the staging system involves specific and characteristic findings and features:'''
-According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
-OR
-The staging of [malignancy name] is based on the [staging system].
-OR
-There is no established system for the staging of [malignancy name].
+* Based on the presence of [[ischemia]]
+** [[Ischemia|Ischemic]] [[Dilated cardiomyopathy|DCM]]: In which the underlying cause is related to ischemia like [[Coronary heart disease|coronary artery disease]].
+** Non-ischemic [[Dilated cardiomyopathy|DCM]]: In which ischemia was not he main driver of DCM [[pathogenesis]].
+* Based on the mode of [[Inheritance (genetic algorithm)|inheritance]]:
+** [[Familial]]: In which an inherited genetic [[mutation]] started the [[myopathy]] process
+** Non-familial: related to other causes as [[Infection|infections]], [[Toxin|toxins]], [[:Category:Drugs|drugs]], and [[peripartum cardiomyopathy]]
+*
 ==References==

Dilated cardiomyopathy classification: Difference between revisions

Latest revision as of 12:27, 30 December 2019

Overview

Classification

References

Navigation menu